INS and diabetes mellitus: Bexagliflozin reduced insulin dose and improved glycemic control in combination with insulin in five poorly controlled diabetic cats [9] and controlled hyperglycemia and clinical signs as the sole therapy in 68 out of 84 (81%) cats with newly diagnosed DM [8].